|
| Wednesday, November 27, 2024 |
|
|
Kingworld-Longde Life and Health Industrial Park Grand Opening |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced that the Group's Kingworld-Longde Life and Health Industrial Park ("Longde Health Industrial Park" or "Industrial Park") in Bao'an Technology City, Longgang District, Shenzhen, has officially commenced operations. more info >> |
|
| Monday, August 28, 2023 |
|
|
Net Profit of Kingworld Medicines Increased By 55.8% |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced its unaudited interim results for the year ended 30 June 2023 (the "Reporting Period" or the "First Half of 2023") . more info >> |
|
| Wednesday, August 16, 2023 |
|
|
Kingworld Further Subscribed For 2.08% Equity of Taiko Pharmaceutical To Optimize Its Layout of Pharmaceutical Industry |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced on 15th that the Group plans to further subscribe for the shares of Taiko Pharmaceutical Co., Ltd. more info >> |
|
| Wednesday, August 2, 2023 |
|
|
Kingworld Medicines Expects 1H Profit Increased By 35%-40% |
| Kingworld Medicines Group ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced a projected rise in profit for the first half of the fiscal year. more info >> |
|
| Tuesday, February 28, 2023 |
|
|
Kingworld Medicines Earns "Shenzhen Time-honored Brand" Title Again |
| Headquartered in Shenzhen, Kingworld Medicines Group Limited (stock code: 01110.HK) is a distributor and the agent of many well-known and high-quality health products, providing channels and supply chains to the products. more info >> |
|
| Wednesday, March 30, 2022 |
|
|
Kingworld Medicines Sees 2021 Profit Soar 159% to RMB30.3 Million |
| Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing world-famous greater health products, announced today its audited consolidated results for the year ended 31 December 2021. more info >> |
|
| Wednesday, March 23, 2022 |
|
|
Kingworld Medicines Group Issues Positive Profit Alert for 2021 |
| Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record an approximately 155% to 160% increase in profit attributable to owners of the Company for 2021, as compared to RMB11.7 million for 2020. more info >> |
|
| Tuesday, March 31, 2020 |
|
|
Kingworld Medicines Seizes the Opportunity Foster the Diversified Development of Product Specifications |
| Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater healthcare products and services industry in China, has announced its unaudited annual results for the year ended 31 December 2019 (the "Year Under Review"). more info >> |
|
| Tuesday, August 27, 2019 |
|
|
Steady Development in Kingworld 25th Anniversary and Deepening Management New Journey in Pursuit of Quality and Healthy Living |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading global well-known omni-channel enterprise offering a complete supply chain spanning the greater health products and services industry, has announced its unaudited interim results for the six months ended 30 June 2019 (the "Period").
more info >> |
|
| Thursday, March 28, 2019 |
|
|
Kingworld Medicines Strengthening Sales Strategy and Channel Coverage; Optimizing Structure by Introducing New Products; Sales of Nin Jiom Significantly Increased by 25.6% |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater health products and services industry in China, has announced its audited annual results for the year ended 31 December 2018 (the "Year Under Review").
more info >> |
|
|
|
